Abstract:Alzheimer’s disease (AD) is a progressively worsening disease that affects specific brain areas involved in spatial memory, short-term memory and has a negative impact on the individual, limiting his ability of independent life. AD remains asymptomatic for a considerable time before cognitive decline becomes clinically evident. For this reason, the establishment of appropriate nutritional protocols, in the early stage, may be more effective than any drug treatments in the fight against this disease. Ketogenic Diet (KD) is a diet high in fat, adequate-proteins and low carbohydrates producing ketone bodies (KBs) (alternative energy source to glucose for the brain). Nowadays, relations between KBs and cerebral Aβ accumulation are not clear. Most studies focus on the neuronal component and forget the vascular component of AD represented by the blood-brain barrier (BBB), located at the cerebral microvessels level. Consequently, it seems essential to focus on the BBB physiology, and in particular on the BBB’s functions of the receptors/transporters and enzymes involved in Aβ peptide transport and metabolism, to better understand the influence of a KD on the onset and the evolution of this disease. For 4 weeks, Wild type mice (129SV) were maintained on KD and Control Diet (CD). Glucose and Beta-hydroxybutyrate (BHB) levels were assessed in blood sample. Microvessel fractions were isolated from total brain and qPCR analyses were performed to study expression of transporters, receptors and enzymes involved in amyloid transport and metabolism at the BBB level. KD fed animals showed increased levels of BHB which was accompanied by an increased expression of Monocarboxylate Transporters 1 (MCT1) and Glucose transporter 1 (GLUT1) at the BBB level. There were not changes in the level of Glucose and body weight in these mice. In addition we observed modifications in the expression of some transporters involved in Aβ exchanges such as Low density lipoprotein receptor-related protein 1 (LRP1) and Multidrug resistance-associated protein 1 (MRP1). The expression of Aβ synthesis enzymes remains unchanged, instead an increase for the Aβ degradation enzyme Endothelin Converting Enzyme 1 (ECE1) was observed. These preliminary results show that dietary factors and in particular KD can modulate the expression of some actors implicated in brain Aβ metabolism at the BBB level.

Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease

Nicotinamide Forestalls Pathology and Cognitive Decline in Alzheimer Mice: Evidence for Improved Neuronal Bioenergetics and Autophagy Procession

Ketogenic Diet Ameliorates Cognitive Impairment and Neuroinflammation in a Mouse Model of Alzheimer’s Disease

Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease

Alternate-day fasting improves cognitive and brain energy deficits by promoting ketone metabolism in the 3xTg mouse model of Alzheimer's disease

Ketone production by ketogenic diet and by intermittent fasting has different effects on the gut microbiota and disease progression in an Alzheimer’s disease rat model

Ketogenic diet: a nutritional protocol for a non-pharmacological treatment of Alzheimer’s disease

Ketogenic interventions restore cognition and modulate peripheral metabolic dysfunctions in Alzheimer’s disease mouse models

A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease

Ketogenic diet and BHB rescue the fall of long-term potentiation in an Alzheimer’s mouse model and stimulates synaptic plasticity pathway enzymes

Ketogenic Approaches for the Treatment of Alzheimer's Disease

Are ketogenic diets promising for Alzheimer’s disease? A translational review

Ketogenic β‐hydroxybutyrate regulates β‐hydroxybutyrylation of TCA cycle‐associated enzymes and attenuates disease‐associated pathologies in Alzheimer's mice

Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice

Nutritional Ketosis and photobiomodulation remediate mitochondria warding off Alzheimer's disease in a diabetic, ApoE4+ patient with mild cognitive impairment: A case report

Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease

A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis

Impaired Glucose Tolerance and Reduced Plasma Insulin Precede Decreased AKT Phosphorylation and GLUT3 Translocation in the Hippocampus of Old 3xTg-AD Mice.

Supplementation of Medium-Chain Triglycerides Combined with Docosahexaenoic Acid Inhibits Amyloid Beta Protein Deposition by Improving Brain Glucose Metabolism in APP/PS1 Mice

The cerebral hypometabolism model of Alzheimer's disease explored: can a ketogenic diet improve cognition in Alzheimer's disease? A review of the literature

Ketogenic Diet Alleviates Cognitive Dysfunction and Neuroinflammation in APP/PS1 Mice Via the Nrf2/HO-1 and NF-κB Signaling Pathways